What is the current market valuation of the celiac disease-treatment market in Germany?

The market valuation was $45.8 Million in 2024. Read More

What is the projected market valuation for the celiac disease-treatment market in Germany by 2035?

The projected valuation for 2035 is $70.81 Million. Read More

What is the expected CAGR for the celiac disease-treatment market in Germany during the forecast period 2025 - 2035?

The expected CAGR is 4.04% during the forecast period 2025 - 2035. Read More

What was the market size for Gluten Free Diet in the celiac disease-treatment market in Germany in 2024?

The market size for Gluten Free Diet was between $20.0 Million and $30.0 Million in 2024. Read More

What is the projected market size for Vitamin and Minerals Supplements in the celiac disease-treatment market in Germany by 2035?

The projected market size for Vitamin and Minerals Supplements is expected to be between $15.0 Million and $25.0 Million by 2035. Read More

What end-user segments are present in the celiac disease-treatment market in Germany?

End-user segments include Hospitals and Clinics, Research Centers, and Others. Read More

What was the market size for Hospitals and Clinics in the celiac disease-treatment market in Germany in 2024?

The market size for Hospitals and Clinics was between $20.0 Million and $30.0 Million in 2024. Read More

How does the market for medical therapies compare to other treatment types in the celiac disease-treatment market in Germany?

Medical Therapies had a market size of $10.8 Million to $15.81 Million in 2024, indicating a smaller segment compared to others. Read More

Germany Celiac Disease Treatment Market

Q: Which companies are considered key players in the celiac disease-treatment market in Germany?

Key players include AbbVie, Gluten Free Holdings, General Mills, Kraft Heinz, Nestle, Pinnacle Foods, Schär, and Crown Bakeries. Read More

Q: What are the main treatment types available in the celiac disease-treatment market in Germany?

Main treatment types include Gluten Free Diet, Vitamin and Minerals Supplements, and Medical Therapies. Read More

ID: MRFR/HC/49599-HCR

200 Pages

Nidhi Mandole

Last Updated: February 06, 2026

Germany Celiac Disease Treatment Market Research Report: Size, Share, Trend Analysis By Treatment Type (Gluten Free Diet, Vitamin and Minerals Supplements, Medical Therapies) and By End Users (Hospitals and Clinics, Research Centers, Others) - Growth Outlook & Industry Forecast 2025 To 2035

Germany Celiac Disease Treatment Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)4.04%

2024 Market Size$ 45.8 Million

2025 Market Size$ 47.65 Million

2035 Market Size$ 70.81 Million

Key Players

AbbVie

Gluten Free Holdings

General Mills

Kraft Heinz

Nestle

Pinnacle Foods

Trends

Rising Demand for Gluten-Free Products
Innovative Treatment Approaches
Enhanced Regulatory Support

Opportunities

Supportive Healthcare Policies
Growing Gluten-Free Food Industry
Increasing Awareness of Celiac Disease

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Treatment Type (USD Million)
  1. 4.1.1 Gluten Free Diet
  2. 4.1.2 Vitamin and Minerals Supplements
  3. 4.1.3 Medical Therapies
2. 4.2 Pharmaceutical, BY End User (USD Million)
  1. 4.2.1 Hospitals and Clinics
  2. 4.2.2 Research Centers
  3. 4.2.3 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 AbbVie (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Gluten Free Holdings (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 General Mills (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Kraft Heinz (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Nestle (CH)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Pinnacle Foods (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Schär (IT)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Crown Bakeries (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 GERMANY MARKET ANALYSIS BY TREATMENT TYPE
3. 6.3 GERMANY MARKET ANALYSIS BY END USER
4. 6.4 KEY BUYING CRITERIA OF PHARMACEUTICAL
5. 6.5 RESEARCH PROCESS OF MRFR
6. 6.6 DRO ANALYSIS OF PHARMACEUTICAL
7. 6.7 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
8. 6.8 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
9. 6.9 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
10. 6.10 PHARMACEUTICAL, BY TREATMENT TYPE, 2024 (% SHARE)
11. 6.11 PHARMACEUTICAL, BY TREATMENT TYPE, 2024 TO 2035 (USD Million)
12. 6.12 PHARMACEUTICAL, BY END USER, 2024 (% SHARE)
13. 6.13 PHARMACEUTICAL, BY END USER, 2024 TO 2035 (USD Million)
14. 6.14 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TREATMENT TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

Germany Pharmaceutical Market Segmentation

Pharmaceutical By Treatment Type (USD Million, 2025-2035)

Gluten Free Diet
Vitamin and Minerals Supplements
Medical Therapies

Pharmaceutical By End User (USD Million, 2025-2035)

Hospitals and Clinics
Research Centers
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”